Dementia and Alzheimer's disease doctors share the symptoms they would always take seriously including forgetfulness, mood ...
The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.
Dementia affects more than 6 million Americans and U.S. cases are expected to double by 2060, so it’s worth knowing when to ...
New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...
Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
Cerezen™, a new treatment which has been shown to reverse symptoms of Alzheimer’s in some cases, was certified in the EU this ...
Dementia is an umbrella term that describes several conditions associated with an ongoing decline in brain functioning ...
Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first medication ...
It's often termed 'mild cognitive impairment' (MCI) as the symptoms are not severe enough to be diagnosed as dementia. "You might not notice these symptoms if you have them, and family and friends may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback